You are here

  • Home
  • Archive
  • Volume 14, Issue 4
  • Review: adding dexamethasone to standard therapy reduces short-term relapse for acute migraine in the emergency departmentCommentary

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: adding dexamethasone to standard therapy reduces short-term relapse for acute migraine in the emergency department

https://doi.org/10.1136/ebm.14.4.121

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    QUESTION

    Does dexamethasone prevent relapse in patients presenting to the emergency department (ED) with acute migraine headache?

    REVIEW SCOPE

    Included studies evaluated adjuvant dexamethasone for acute migraine headache diagnosed and treated in the ED and reported the proportion of patients with self-reported moderate or severe headache at 24–72 hours as an outcome. Moderate or severe headache was defined as severe headache that interferes with daily activities or requires a physician visit (last 2 categories on a 5-point scale), moderate or severe headache (last 2 categories on a 4-point scale), or presence of headache on a dichotomous scale. Other outcomes included adverse events.

    REVIEW METHODS

    Randomised controlled trials (RCTs) in which patients and treating physicians were blinded were retrieved from Medline (1950–May …

    View Full Text

    Footnotes

    • Source of funding: no external funding.